C
한독
002390KOSPI50.0 / 100
Reference Date: 2026-10-23
Financial Score21.5 / 40
News Sentiment12.5 / 25
Momentum6.0 / 20
Disclosure10.0 / 15
AI Analysis: PBR is significantly undervalued vs. peers but ROE is below the industry average. Slightly down 3.7% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
Han Dong, established in 1954, operates in pharmaceuticals, medical devices, health functional foods, and real estate leasing. Key products include Amaryl, Tenelria, and RediQ, with headquarters in Seoul's Gangnam-gu, a factory in Yongcheon, Chungcheongbuk, and a research institute in Gangseo-gu, Seoul. The company operates across multiple business segments.
Number of Employees
951people
Average Salary
78.0M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 15.004.0Point
PBR
0.43Industry Average 1.207.0Point
Half of industry avg (excellent)
ROE
-0.79Industry Average 8.000.0Point
Well below industry avg
Debt Ratio
34.98Industry Average 100.006.5Point
Half of industry avg (excellent)
Trend 2023~20254.0 / 10 points
Revenue Growth Rate
1.0 / 3
Avg ▲1.3% (2-year basis)
Operating Profit Growth Rate
3.0 / 3
Avg ▲207.8% (2-year basis)
ROE Trend
0.0 / 4
Avg ROE -8.5% (improving, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position3.0Point
52w lower range (35%)
Current 8,600Won52-week high 12,07052-week low 6,700
1-month return2.0Point
1m -3.70% (slight drop)
Volume trend1.0Point
Volume decreasing
Detailed Disclosure
0 totalPositive 0Neutral 0Negative 0